Khurram Bashir, M.D., M.P.H.
Director, Division of Neuroimmunology and Multiple Sclerosis
Director, Multiple Sclerosis Center
Director, Neurology Residency Program
Professional Background: M.D., King Edward Medical College, Lahore, Pakistan, 1990; MPH (epidemiology), UAB, 2001
Office: SC 440F, 1720 7th Avenue South, Birmingham AL 35294-0017
Dr. Bashir has a M.B. and B.S. degree in Medicine from King Edward Medical College in Lahore, Pakistan. He also obtained a Masters in Public Health in epidemiology from the University of Alabama at Birmingham. He completed an internal medicine internship at Southern IIlinois University at Springfield from 1992-1993 and also a combined internal medicine and neurology residency there from 1993-1997. From 1997-1999, he completed a neuroimmunology/MS fellowship under the leadership of John N. Whitaker, M.D., with the UAB Department of Neurology, and in March of 2000, he was appointed Assistant Professor of Neurology.
Currently Dr. Bashir is Director of the Division of Neuroimmunology and Multiple Sclerosis, Director of the Multiple Sclerosis Center, Co-Director of the Center for Neuroimmunology, Director of the Neuroimmunology/Multiple Sclerosis Fellowship Program, Director of the Neurology Residency Program, Co-Director of the Center for Pediatric Onset Demyelinating Diseases, Medical Director of the Birmingham VA Multiple Sclerosis Clinic at the Birmingham Veterans Medical Center, and also Medical Director of the National MS Society Second Opinion Clinic for UAB and the National MS Society Alabama Chapter.
Specialty / Interests
Clinical, epidemiological and outcomes research in immunologic disorders of the central nervous system, specifically multiple sclerosis
Whitaker JN, Bashir K, Benveniste EN. Cerebrospinal Fluid. In: Cook SD, ed. Handbook of Multiple Sclerosis. Third Edition. Marcel Dekker, Inc., New York and Basel, 2000;347-375.
Bashir K, Cai CY, Moore TA, Whitaker JN, Hadley MN. Surgery for cervical spinal cord compression in patients with multiple sclerosis. Neurosurgery 47:637-642, 2000
Bashir K, Whitaker JN. Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Multiple Sclerosis 6:312-316, 2000
Bashir K, Whitaker JN. Handbook of Multiple Sclerosis. Lipincott, Williams & Wilkins, Philadelphia, PA. 2001.
Bashir K, Hadley MN, Whitaker JN. Surgery for spinal cord compression in multiple sclerosis. Current Opinion in Neurology 14:765-769, 2001.
Bashir K. Balo’s concentric sclerosis. In: Gilman S, Goldstein GW, Waxman SG, editors. MedLink,. San Diego: Arbor Publishing: 8th ed, 2001.
Cohen JA, Cutter GR, Fischer JS, et al for the IMPACT Investigators. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol 58:961-967, 2001
Bashir K, Whitaker JN. Current immunotherapy for demyelinating diseases. Arch Neurol 2002;59:726-731.
Bashir K. Balo's concentric sclerosis. In: Gilman S, Goldstein GW, Waxman SG, editors. MedLink, San Diego: Arbor Publishing: 9th ed, 2002.
Jeffery D, Bashir K, Buchwald L, Coyle P, Freedman M, Markowitz C, Rammohan K, Reder T, Sharief M, Wolinsky J. Optimizing immunomodulatory therapy for MS patients: an integrated management model. (Letter) J Neurol Sci 201(1-2):89-90, 2003.
Wolinsky JS and the PROMiSe Study Group. The diagnosis of primary progressive multiple sclerosis. J Neurol Sci 206(2):145-152, 2003.
Wolinsky JS, The PROMiSe Study Group. The PROMiSe trial: Baseline data review and progress report. Multiple Sclerosis 10:S65-S72, 2004.
The North American Study Group on Interferon beta-1b in Secondary Progressive MS. Interferon beta-1b in secondary progressive MS. Neurology 63:1788-1795, 2004.
Agius M, Bashir K, Bashir R, Cohen BA, Collins TE, Fox E, Herndon R, Jeffery DR, Khan O, Kinkel O, Kinkel P, Mikol Picone MA, Rivera V, Rizvi S, Tornatore C. Zwibel H. Identifying and treating suboptimal response. Neurology 63(Suppl 6):S33-S40, 2004.
Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354(9):911-23, 2006.
Wolinsky JS, Narayana PA, O'Connor P, Coyle PK, Ford C, Johnson K, Miller A, Pardo L, Kadosh S, Ladkani D, PROMiSe Trial Study Group. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol 61(1):14-24, 2007.
Dr. Bashir in Health System Directory